24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Cancer genetics<br />

<strong>of</strong> UVs newly found in patients .<br />

We used different publicly available programs and web-based tools to<br />

identify UVs that may have deleterious effects with respect to different<br />

biomolecular functional categories (splicing regulation, transcriptional<br />

regulation, nonsynonymous amino acid SNP effect . . .) so their clinical<br />

significance in cancer etiology could be assumed.<br />

Using straightforward physical and comparative considerations, we<br />

have found that several sequence variants with nonsynonymous amino<br />

acid change could have possible impact on the structure and function<br />

<strong>of</strong> a BRCA1 and BRCA2 proteins . Synonymous amino acid changes<br />

(silent mutations) could have impact on splicing regulation by disrupting<br />

exonic splice enhancers . Intronic sequence variants showed no<br />

potential impact on splicing because nucleotide changes at that positions<br />

likely make no changes in consensus splice sites .<br />

In Silico analysis <strong>of</strong> BRCA1 and BRCA2 presents fast, easy and cheap<br />

method for assessing preliminary clinical significance for UVs, especially<br />

in cases with low frequency and ethnic specific alleles, when<br />

it is difficult to make population based studies and when expensive<br />

experimental functional assays must be performed .<br />

P04.069<br />

three years <strong>of</strong> real-time PcR-based gene dosage for<br />

BRCA large rearrangements in France : new perspective in<br />

combination with HRm curve analysis<br />

C. Lefol, E. Rouleau, G. Christophe, F. Copigny, C. Andrieu, I. Bieche, R. Lidereau;<br />

Centre Rene Huguenin, St Cloud, France.<br />

BRCA1 germline mutations are responsible for susceptibility in breastovarian<br />

cancers . Some alterations are large rearrangements (15%) .<br />

To detect them, our laboratory has proposed a real-time PCR-based<br />

gene dosage . Since 2004, samples from all <strong>of</strong> over France have been<br />

analyzed with this method to confirm large rearrangements detected<br />

with semi-quantitative multiplex PCR (MLPA or QMPSF) . Recently, our<br />

qPCR experience have been transfer to LightCycler 480 combining<br />

High-Resolution Melting curve analysis .<br />

For each genomic DNAs sent, suspected exons were scanned with<br />

a few others . Copy numbers <strong>of</strong> each exon were calculated with an<br />

algorithm based on delta Ct method . As reference <strong>of</strong> the diploidy, three<br />

genes (4q, 8q, 17q) were quantified.<br />

148 samples have been analysed with ABI Prism 7900 and PowerSybr<br />

Mix. 49 rearrangements were confirmed (table). 99 samples have no<br />

rearrangement . Most <strong>of</strong> those BRCA1 large rearrangements were analysed<br />

and validated with LightCycler 480 and HRM Master Mix using<br />

the same qPCR primers . Furthermore, by applying the same algorithm<br />

and PCR conditions, selected HRM primers were also able to detect<br />

those rearrangements .<br />

This large series confirms the abilities <strong>of</strong> qPCR to detect large rearrangements<br />

in a routine screening . HRM curve analysis combined with<br />

quantitative PCR can give in unique assay information for point mutations<br />

and large rearrangements . Therefore, this technique should be<br />

reconsidered as a first-line tool for BRCA1 screening .<br />

Result <strong>of</strong> 148 suspected BRCA1 large rearrangements by real-time<br />

PCR-based gene dosage<br />

Number <strong>of</strong> Number <strong>of</strong> con-<br />

%<br />

samples firmation<br />

Deletion suspected 101 35 35%<br />

Duplication suspected<br />

16 4 25%<br />

(5’region to exon 1-2)<br />

Duplication suspected<br />

31 10 30%<br />

(others exons)<br />

P04.070<br />

characterization <strong>of</strong> some acute lymphoblastic leukemia cases<br />

by cytogenetic technique<br />

D. Usurelu1 , L. Gavrila1 , D. Cimponeriu1 , P. Apostol1 , L. Dan1 , I. Radu1 , V. Teleanu2<br />

, A. Moicean2 , A. Dumitrescu2 ;<br />

1 2 Institute <strong>of</strong> <strong>Genetics</strong>, Bucharest, Romania, Fundeni Hospital, Bucharest, Romania.<br />

Cytogenetical analyses are important for diagnostics, prognostic and<br />

monitoring <strong>of</strong> the treatment efficiency in leukemia.<br />

Objective:<br />

Cytogenetical characterization <strong>of</strong> some Romanian patients with acute<br />

lymphoblastic leukemia (ALL) .<br />

material and methods:<br />

Five patients with ALL from Fundeni hospital, Bucharest were analyzed<br />

.<br />

Bone marrow cells were cultivated in specific medium for 96 hours. The<br />

slides were prepared according to the classical procedure and stained<br />

with Giemsa solution . 100 metaphases/patient were analyzed .<br />

The cytogenetic analyses follow two directions:<br />

- detection <strong>of</strong> chromosomal aberrations and identification <strong>of</strong> t(9;22)<br />

- evaluation <strong>of</strong> a potential link between leukemic phenotype and the<br />

telomeres structure .<br />

Results and conclusion:<br />

An obvious genomic instability <strong>of</strong> the leukemic cells was noticed, expressed<br />

by different chromosomal rearrangements, as well as by genomic<br />

mutation i .e . aneuploidy (table) .<br />

Chromosomal rearrangements<br />

Normal<br />

Telomere-to-telomere<br />

Patients<br />

Aneuploidy<br />

ring chromo-<br />

metaphases PCD<br />

and telomere-to- centro- Fusions<br />

(>50chromosomes)<br />

somesmere<br />

attractions<br />

1 43 10 1 8 12 0<br />

2 55 15 3 2 7 1<br />

3 29 11 0 1 5 0<br />

4 48 13 8 3 3 2<br />

5 35 20 5 7 7 0<br />

The FISH analyses showed the t(9;22) was present in two patients. This translocation<br />

was present in 57% <strong>of</strong> the metaphases <strong>of</strong> the first patient and in 71% <strong>of</strong> the metaphases<br />

<strong>of</strong> the third one.<br />

No correlation between the telomere length and the leukemic phenotype could be<br />

detected. The fluorescence signal was encountered in more than 97% <strong>of</strong> the chromosomes,<br />

that indicates almost intact telomeric repetition, without large terminal deletions.<br />

The incidence <strong>of</strong> t(9;22) found in two out <strong>of</strong> five patients is comparable to other studies<br />

taking in acount also that they didn’t receive any treatment, being at the diagnostic<br />

stage.<br />

P04.071<br />

chromosomes 3 and 7 rearrangements in complex<br />

chromosomal aberrations in patients with myelodysplastic<br />

syndromes and acute myeloid leukemia<br />

J. Brezinova 1 , Z. Zemanova 2 , L. Babicka 2 , S. Izakova 1 , J. Cermak 1 , M. Siskova<br />

3 , K. Michalova 1,2 ;<br />

1 Institute <strong>of</strong> Hematology and Blood Transfusion, Prague, Czech Republic,<br />

2 Center <strong>of</strong> Oncocytogenetics Institute <strong>of</strong> Clinical Biochemistry and Laboratory<br />

Diagnostics General Faculty Hospital and 1st Faculty <strong>of</strong> Medicine <strong>of</strong> Charles<br />

University, Prague, Czech Republic, 3 1st Medical Department General Faculty<br />

Hospital and 1st Faculty <strong>of</strong> Medicine <strong>of</strong> Charles University, Prague, Czech<br />

Republic.<br />

Rearrangements <strong>of</strong> chromosomes 3 and 7 are frequent in myelodysplastic<br />

syndromes (MDS) and acute myeloid leukemia (AML) and are<br />

associated with poor outcome and resistance to treatment . Combinations<br />

<strong>of</strong> molecular cytogenetic techniques were used for identification<br />

<strong>of</strong> these rearrangements in bone marrow cells <strong>of</strong> patients with complex<br />

chromosomal aberrations (CCA) . In cohort <strong>of</strong> 392 patients with AML<br />

and RAEBt (refractory anemia with excess blast in transformation) we<br />

proved CCA in 58 <strong>of</strong> them . Chromosome 3 was involved in complex<br />

aberrations in 26 patients, chromosome 7 in 23 patients, both chromosomes<br />

3 and 7 in nine patients . The most frequent aberrations <strong>of</strong><br />

chromosome 3 were non-reciprocal translocation combined with deletion<br />

<strong>of</strong> chromosome 3 (14 patients) . Other abnormalities proved by<br />

FISH: non-reciprocal translocations without deletion (8 patients), reciprocal<br />

translocation (5 patients), partial trisomy (4 patients), inversion<br />

(1 patient) and insertion <strong>of</strong> a part <strong>of</strong> chromosome 3 into chromosome<br />

2 (1 patient) . Breakpoints 3p24 .2 and 3q26 were the most frequent .<br />

Minimal deleted segment 3p25-3pter was ascertained in 12 patients .<br />

Similarly, large heterogeneity <strong>of</strong> the breakpoints and various extent <strong>of</strong><br />

deletion were proved on chromosome 7 with the most frequent breakpoints<br />

7q31 and 7p12 . Partners in translocations were chromosomes<br />

5, 3 and 12 . Using combination <strong>of</strong> molecular cytogenetic techniques<br />

we found a wide variety <strong>of</strong> aberrations not detectable by conventional<br />

cytogenetic analysis . We presume contribution <strong>of</strong> more genes and participation<br />

<strong>of</strong> epigenetic factors in the origin and during the course <strong>of</strong><br />

the disease .<br />

Supported by grants IGA NR 9227-3, MZO 00023736, MSMT LC535 .<br />

0

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!